Clinical Trial Update: Efficiency Study of Triple-Site Cardiac Resynchronization in Patients With Heart Failure [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating triple-site cardiac resynchronization therapy in patients with heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Heart Failure

Snippet

Sponsor: Silesian Centre for Heart Diseases | Conditions: Congestive Heart Failure, Heart Disease | Phase 2, Phase 3 | Status: COMPLETED